Epiminder Limited (ASX: EPI) - ETF Exposure

Current share price for EPI : $0.265 0.025 (10.42%)⁺

Epiminder Limited (EPI) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Headquartered in Melbourne, Australia, the Company also has a presence in Sydney, Australia and in the US.

EPI General Information ⁺

ASX Code	EPI
Website	http://epiminder.com
Industry/Sector	Health Care Equipment
Market Cap ($M)	46
EPI Share Price	$0.265
Day High	$0.265
Day Low	$0.255
Last Close	$0.240
EPI Share Price Movement	$0.03 ( 10.42% )

Prices as at 16:40, 6 Nov 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to EPI

Epiminder Limited (EPI) is held across 1 ETF spanning strategies that include health care equipment exposure . Its weighting in those funds means performance can have an outsized influence - when EPI moves, funds like TCAP that hold it can move with it.

For more concentrated exposure, ETFs such as TCAP (Ten Cap Alpha Plus Complex ETF) allocate about 0.1% to EPI , while the average exposure across all 1 ETF that hold it is around 0.1% .

Top ETF holdings

Ten Cap Alpha Plus Complex ETF (TCAP) ~ 0.1%

Last updated: ETF data and holdings as at 6 November 2026

Own EPI directly or through an ETF?

How does holding Epiminder Limited (EPI) shares directly compare to ETFs that include it?

	EPI Direct	TCAP ASX
Holdings	1 company	105 holdings
EPI Weight	100%	0.1%
Diversification	Single Stock	Broad
Annual Cost	Brokerage only	0.97% p.a.
Approx. Yield	0%	2.69%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not EPI's direct yield. Annual cost uses each ETF's MER.

EPI Exposure on $10,000 investment

How a $10,000 investment in Epiminder Limited (EPI) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Epiminder Limited (EPI)	Direct share	$0.265	0%	$0	$10,000
Ten Cap Alpha Plus Complex ETF (TCAP)	Equity - Australia Strategy	$9.690	0.52%	+$52	$10,052

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Epiminder Limited (EPI) ETFs

1 ETF hold Epiminder Limited (EPI).

ETF	EPI Weight	MER	Yield
Ten Cap Alpha Plus Complex ETF (TCAP)	0.1%	0.97%	2.69%

Epiminder Limited (EPI) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
Interim	1¢	0%	22 Nov 1996	6 Dec 1996	-	-	-

See all dividends from Epiminder Limited (EPI) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Epiminder Limited (EPI) price-sensitive announcements

EPI - CMS Increases Medicare Payment for the Minder System CY 2027

Epiminder Limited announced that the US Centers for Medicare & Medicaid Services finalised

Epiminder Limited (EPI)
6 Nov 2026 | 9:51 AM

EPI - Minder System Cleared for Patients 12 -75 Years of Age

Epiminder Limited (ASX: EPI) announced that the U.S. Food and Drug Administration has clea

Epiminder Limited (EPI)
30 Oct 2026 | 11:11 AM

EPI - FY27 YTD operational update and AGM materials

Epiminder’s FY27 year-to-date operational update and AGM materials report strong progress

Epiminder Limited (EPI)
30 Oct 2026 | 9:46 AM

EPI - Quarterly Activities/Appendix 4C Cash Flow Report

Epiminder Limited (ASX: EPI) reported its Appendix 4C quarterly cash flow for the quarter

Epiminder Limited (EPI)
28 Oct 2026 | 9:06 AM

Epiminder Limited (EPI) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Epiminder Limited (EPI) ORDINARY FULLY PAID	Health Care	$46	CMS Increases Medicare Payment for the Minder System CY 2027	6 Nov 2026 9:51AM	$0.240	$0.265	risen by 10.42%
Epiminder Limited (EPI) ORDINARY FULLY PAID	Health Care	$46	Resignation of Chief Financial Officer	4 Nov 2026 10:03AM	$0.255	$0.265	risen by 3.92%
Epiminder Limited (EPI) ORDINARY FULLY PAID	Health Care	$46	Change of Address	2 Nov 2026 4:07PM	$0.250	$0.265	risen by 6%
Epiminder Limited (EPI) ORDINARY FULLY PAID	Health Care	$46	Results of Annual General Meeting	30 Oct 2026 2:15PM	$0.265	$0.265	fallen by 0%
Epiminder Limited (EPI) ORDINARY FULLY PAID	Health Care	$46	Minder System Cleared for Patients 12 -75 Years of Age	30 Oct 2026 11:11AM	$0.260	$0.265	risen by 1.92%
Epiminder Limited (EPI) ORDINARY FULLY PAID	Health Care	$46	FY27 YTD operational update and AGM materials	30 Oct 2026 9:46AM	$0.265	$0.265	fallen by 0%

EPI Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2026A	-$39.18	-$26.00	45.90%	0.00%	0.0%
2025A	-$31.19	-$17.80	39.30%	0.00%	0.0%
2024A	-$22.39	-$12.80	4.90%	0.00%	0.0%

EPI Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
Cochlear Limited (COH)	$10,100M	-0.3136	0.2540	0.0785	37.5995	29.9837	27.8015	2.23%	2.32%	2.53%
Epiminder Limited (EPI)	$42M	0.4590	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Fisher & Paykel Healthcare Corporation Limited (FPH)	$22,878M	0.1388	0.1427	0.1573	58.8084	51.4622	44.4660	1.11%	1.20%	1.34%
Imricor Medical Systems Inc (IMR)	$470M	-0.4254	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
ResMed Inc. (RMD)	$19,362M	9.5922	0.1125	0.0881	22.4726	20.2008	18.5646	1.03%	1.09%	1.18%

EPI Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	0.70	0.00
Market	0.30	13.40	1.03	0.75
Sector	0.69	20.50	1.77	2.67

EPI Directors

Name	Position	Start Date
Dr Rohan Hoare	Chief Executive Officer, Managing Director	7 Dec 2022
Mr Philip Binns	Non-Executive Chairman, Non-Executive Director	27 Jun 2018
Mr Jeffrey Sells	Non-Executive Director	4 May 2025
Mr Donal Paul O'Dwyer	Non-Executive Director	30 Apr 2025
Mr Robert John Klupacs	Non-Executive Director	25 Sep 2017
Ms Patricia ORourke	Non-Executive Director	1 Jan 0001

Epiminder Limited (EPI) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
1 Oct 2026	O'DWYER, Donal	Buy	Indirect Shares	75,000	$0.265	$19,874.970
2 Sep 2026	O'DWYER, Donal	Buy	Indirect Shares	50,000	$0.330	$16,500.000
1 Sep 2026	O'DWYER, Donal	Buy	Indirect Shares	50,000	$0.351	$17,550.000

See all changes in directors' interest & trades for Epiminder Limited (EPI) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EPI Management

Name	Position
Mark McLellan	Chief Financial Officer,Joint Company Secretary
John Heasman	COO
Belinda Ann Cleminson	Joint Company Secretary

EPI Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Epiminder Limited (EPI). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
110,289,228 (50.90%)	Cochlear Investments Pty Ltd
15,773,644 (7.30%)	The Bionics Institute of Australia

EPI Calendar of Events

Date	Event
25 August 2027	Report (Annual)
25 August 2027	Report (Prelim)
24 February 2027	Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us